prevents apoptosis in U937 myelocytic leukemia cells and TF-1 erythroleukemia cells, led us to examine the effects of As 2 O 3 on cell growth and PML/RAR␣ expression in a variety of retinoic acid-resistant NB4 subclones. We now report that As 2 O 3 induces loss of the fusion protein PML/RAR␣ but not of its messenger RNA (mRNA) in both retinoic acid-sensitive and retinoic acid-resistant cell lines, leading to apoptosis without morphologic differentiation. Thus, in cells that express PML/ RAR␣ protein, PML/RAR␣ may be a common target for both retinoic acid and As 2 O 3 , and loss of PML/RAR␣ regulation by retinoic acid does not prevent its regulation by As 2 O 3 . We examined the effects of As 2 O 3 in U937 cells stably transfected with PML/RAR␣ as well as in fresh leukemia cells derived from patients with APL. To develop hypotheses explaining why the As 2 O 3 -induced loss of PML/RAR␣ leads to apoptosis while retinoic acid treatment leads to differentiation, we investigated the effects of both compounds in combination, and we examined alterations in gene expression induced by retinoic acid or As 2 O 3 .
Methods
Cell culture and compounds. The parental NB4 promyelocytic leukemia cell line, five retinoic acid-resistant subclones of this line, and the U937 myeloid leukemia cell line were grown in RPMI-medium (Life Technologies, Inc. [GIBCO BRL], Gaithersburg, MD) supplemented with 10% fetal bovine serum (FBS; Upstate Biotechnology Inc., Lake Placid, NY). Peripheral blood was obtained after verbal consent from newly diagnosed patients with APL whose disease was classified as M3 or M3-variant by use of morphologic criteria (French-American-British classification) and who presented with an initial percentage of circulating blast cells that was more than 80%. Confirmation of the presence of the PML/RAR␣ gene was performed as previously described (25) . Leukemia cells were isolated and enriched on Ficoll-Hypaque density gradients (Pharmacia LKB Biotechnology AB, Uppsala, Sweden), washed twice with calcium and magnesium-free phosphate-buffered saline (PBS), and cultured as described above. All cell cultures were incubated at 37°C in humidified air supplemented with 5% CO 2 . A 10-mM stock solution of t-RA (Sigma Chemical Co., St Louis, MO) was prepared in dimethyl sulfoxide. As 2 O 3 (Sigma Chemical Co.) was dissolved in 1 M NaOH, and diluted further to 10 mM in PBS.
Viable cell counts and assays of differentiation. Cell lines were grown in the medium described above in the presence of varying concentrations of As 2 O 3 for 5 or 7 days. Cells were cultured at 25 000/mL, and duplicate samples were counted by use of a hemocytometer. The trypan blue dye (Sigma Chemical Co.) exclusion method was used to count viable cells. Cell differentiation was evaluated on the basis of cellular morphology, changes in cell surface antigen expression, and the nitroblue tetrazolium (NBT) assay (Sigma Chemical Co.). Giemsastained cytospin slides were analyzed for cell morphology by means of light microscopy. Analysis of cell surface antigens was performed by means of flow cytometry (Faxflo cytometer; Becton Dickinson Labware, Bedford, MA); aliquots of 1 × 10 6 cells were stained with antibodies CD11b, CD11c, CD13, and CD15 (26) . The percentage of NBT-positive cells was determined (at least 200 cells per experimental condition) as previously described (27) .
Assays of apoptosis. For DNA fragmentation analysis, cells were pelleted and resuspended in lysis buffer (10 mM Tris-HCl [pH 7.8], 10 mM EDTA, 100 mM NaCl, 0.5% sodium dodecyl sulfate (SDS), and 200 ng/L proteinase K) followed by incubation at 37°C overnight. After phenol:chloroform (1:1) extraction, DNA was precipitated with 2 vol of 100% ethanol and washed twice with 75% ethanol. The DNA pellet was resuspended in TE buffer (10 mM Tris-HCl [pH 8.0] and 1 mM EDTA), and 8 g of DNA was electrophoresed in an ethidium bromide-stained 1.5% agarose gel for the visualization of laddering (caused by internucleosomal cleavages). The TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate [dUTP] nick-end labeling) assay was performed by use of the In Situ Cell Death detection kit (Boehringer Mannheim, Laval, Québec, Canada). DNA strand breaks generated by cleavage of genomic DNA during apoptosis can be identified in this assay by the labeling of free 3Ј-OH termini with fluorescein isothiocyanate (FITC)-conjugated dUTP. Stained cells were analyzed by means of fluorescence microscopy. For samples from patients with APL, the percentage of apoptotic cells among APL blast cells was evaluated by means of double staining with FITC-labeled Annexin-V and propidium iodide (PI) (R&D Systems, Inc., Milan, Italy). Briefly, 5 × 10 4 cells were washed twice with cold PBS and resuspended in 250 L binding buffer (HEPES-buffered saline solution [Life Technologies, Inc.] supplemented with 0.25 mM CaCl 2 ); 10 L FITC-conjugated Annexin-V and 10 L PI reagent were then added to the cells, and the mixture was gently agitated on a vortex mixer and incubated for 15 minutes at room temperature in the dark. Within 1 hour, the cells were analyzed at 488 nm in a FACSCAN cytometer (Becton Dickinson Labware).
SDS-polyacrylamide gel electrophoresis and western blot analysis. Nuclear extracts were prepared from 1 to 5 × 10 8 control cells and treated cells as described previously (26, 27) . Equal amounts of protein were electrophoresed in 10% polyacrylamide gels containing 0.1% SDS and then transferred to nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA). The membranes were probed with an antibody directed against the RAR␣ F domain [provided by P. Chambon (28) (25, 27) . The extracts were subsequently fractionated at 4°C by means of high-performance liquid chromatography (HPLC) using a superose 6 HR 10/30 size-exclusion column (Pharmacia LKB Biotechnology AB). The flow rate was 0.4 mL/minute, fractions of 0.4 mL were collected, and radioactivity was measured with the use of a liquid scintillation counter. The HPLC system was calibrated with a series of molecular weight (MW) markers, including the following: blue dextran, MW 2 000 000; thryoglobulin, MW 669 000; ␤-amylase, MW 200 000; bovine serum albumin, MW 66 000; and ovalbumin, MW 45 000.
Immunohistochemistry. Cells were cytocentrifuged and fixed in 3.7% paraformaldehyde in PBS at room temperature for 10 minutes, followed by an incubation in methanol for 2 minutes. PML immunostaining was performed by use of the monoclonal antibody PGM3 (29) for 1 hour at room temperature. The cells were subsequently stained with a rhodamine-conjugated, anti-mouse secondary antibody (1:600 dilution in PBS) for 30 minutes. After washing with PBS, antibody complexes were detected by use of a fluorescence microscope (Aristoplan-Leitz, Wetzlar, Germany).
Ribonuclease (RNase) protection assay and northern blot analysis. Total cytoplasmic RNA was isolated, and RNase protection analysis was performed as previously described (30) (31) (32) . Hybridization of complementary RNA probes was carried out at 45°C overnight, followed by the addition of 300 L RNase digestion buffer containing 40 g/mL RNase A and 700 U/mL RNase T1. RNase digestion was performed at 25°C for 1 hour, and Rnase-resistant fragments were resolved by means of electrophoresis in 6% polyacrylamide sequencing gels that contained 7.6 M urea. A glyceraldehyde-3-phosphate dehydrogenase probe (Ambion Inc, Austin, TX) was included in all analyses as a control for RNA loading. As approximate size markers, 32 P-labeled Msp I-digested fragments of the plasmid pBR322 were run in all gels. Northern blot analysis was performed as previously described (20) .
Transglutaminase assay. Control or treated cells (approximately 1-5 × 10 6 ) were collected by means of centrifugation and washed twice in calcium and magnesium-free PBS containing 1 mM EDTA and 1 mM phenylmethylsulfonyl fluoride. Cell pellets were resuspended in 200 L of the same solution and sonicated at 4°C. After taking an aliquot for total protein determination, dithiothreitol was added to the remaining sonicate to a final concentration of 10 mM. The sonicate was then centrifuged at 4°C for 5 minutes at 10 000g, yielding soluble (supernatant) and particulate (pellet) fractions. Transglutaminase activity assays were performed as previously described (33) .
Results

Inhibition of Cell Growth Induced by As 2 O 3 in Retinoic Acid-Resistant APL Subclones
We examined the effects of As 2 O 3 on a variety of retinoic acid-resistant NB4 subclones. MR6, R4, and NB4.006 are three resistant subclones developed by maintaining NB4 cells in retinoic acid-containing media (19, 20) . The subclones NB4.306 and NB4.606 were developed by means of mutagenesis with low-dose radiation, followed by culturing in retinoic acidcontaining media (19) . PML/RAR␣ expression can be seen in western blots of the proteins from all resistant subclones except for NB4.306, although several subclones demonstrate altered ligand binding to PML/RAR␣ (20) . The cells were treated with different doses of As 2 O 3 , and viable cells were counted via the trypan blue dye exclusion method. All five retinoic acid-resistant cell lines showed growth inhibition induced by As 2 O 3 in a dosedependent manner, comparable to or greater than the inhibition induced in NB4 cells (Fig. 1 ).
Induction of Apoptosis by As 2 O 3 Without Differentiation in Retinoic Acid-Resistant Cell Lines and in Fresh APL Cells From Patients
NB4 and retinoic acid-resistant subclones were treated with 1 M As 2 O 3 for up to 6 days. Fixed, cytospun samples of each cell line were stained and examined by means of light microscopy, which showed no evidence of morphologic differentiation (data not shown). We then analyzed the expression of three surface antigens after 4 days of culture in 1 M As 2 O 3 or 1 M t-RA. The percentage of cells from NB4 and three retinoic acidresistant sublines (R4, NB4.306, and NB4.606) expressing surface differentiation antigens after 4 days of exposure to either compound is shown in Table 1 . The increased levels of CD11b and CD11c and the reduced level of CD13 in NB4 cells following treatment with 1 M retinoic acid are consistent with the known sensitivity of these cells to retinoic acid-induced differentiation (34) . The three resistant cell lines showed minimal expression of CD11b and CD11c with or without retinoic acid treatment. CD13 expression remained unchanged following treatment with retinoic acid in R4 and NB4.306, although NB4.606 displayed some degree of CD13 reduction. All cell lines, including NB4, showed no alteration in surface antigen expression in the presence of 1 M As 2 O 3 . Thus, consistent with the morphologic studies, As 2 O 3 does not induce markers of cell differentiation.
We then performed assays characterizing cell apoptosis. Cells were treated with 1 M t-RA or 1 M As 2 O 3 , and DNA was isolated and electrophoresed for fragmentation analysis. NB4 cells showed no indication of apoptosis induced by t-RA up to day 3, whereas after 1 day of treatment with 1 M As 2 O 3 , NB4 and the two retinoic acid-resistant lines, MR6 and R4, showed a distinctive DNA laddering pattern (data not shown). We confirmed the induction of apoptosis by As 2 O 3 at the single cell level via the TUNEL assay. This assay labels in situ DNA strand breaks that are produced during apoptosis and these labeled breaks can be detected by means of immunohistochemistry. Cells were treated with 1 M As 2 O 3 and assayed after 1 day. Approximately 2.4% of the untreated NB4 cells showed the positive fluorescent staining that is indicative of apoptosis, whereas 10% of the cells exhibited apoptotic staining after 1 day of As 2 O 3 treatment. The three retinoic acid-resistant cell lines, MR6, R4, and NB4.606, showed comparable levels of cell apoptosis induced by As 2 O 3 (data not shown). To examine the effects of As 2 O 3 on fresh APL cells, leukemia blast cells were isolated from four patients newly diagnosed with APL, and these blast cells were incubated in cell culture medium alone (control) or in medium supplemented with 1 M As 2 O 3 , 1 M t-RA, or both agents combined. After 7 days of culture, cytospun samples of the cells were stained with MayGrünwald-Giemsa and examined by means of light microscopy. Cells treated with t-RA showed morphologic features of granulocytic maturation, whereas no evidence of morphologic differentiation was observed in control cells or in cells exposed to As 2 O 3 . Cells treated with both agents exhibited morphologic signs of granulocytic differentiation but at a level less pronounced than that observed for cells exposed to t-RA alone. In parallel, we evaluated the expression of several membrane antigens in fresh leukemia cells cultured under the same conditions as described above. As shown in Table 2 , we observed the following: 1) cells cultured in the absence of any agent did not undergo changes in surface marker expression; 2) cells cultured in the presence of t-RA acquired the expression of several membrane antigens (CD11b, CD11c, CD18, and CD15) typically expressed in mature phagocytes; 3) As 2 O 3 -treated cells did not develop expression of the majority of membrane-differentiation antigens (CD11b, CD11c, and CD18), with the exception of CD15; and 4) consistent with our morphologic findings, cells cultured in the presence of both agents showed a level of expression of membrane-differentiation antigens lower than that observed in cells exposed to t-RA alone. Thus, in vitro treatment of fresh APL cells with As 2 O 3 does not induce phenotypic differentiation and diminishes the level of differentiation induced by retinoic acid.
We also evaluated the effects of t-RA and As 2 O 3 in combination on apoptosis in APL blast cells. APL cells isolated from patients and cultured in vitro in RPMI-1640 medium containing 10% FBS exhibited a moderate and progressive increase in the rate of spontaneous apoptosis from day 0 to day 7 of culture; this CD11b  10  2  51  3  5  10  4  79  3  31  CD11c  0  0  51  2  32  0  0  54  1  17  CD15  2  29  100  98  99  3  6  99  69  99  CD18  54  48  94  58  50  37  33  95  33  79 *All patients had the t(15;17) translocation. The blast cells were cultured for 7 days in medium alone (control) or in the presence of 1 M all-trans-retinoic acid (t-RA), 1 M arsenic trioxide (As 2 O 3 ), or a combination of both agents. C0 ‫ס‬ control at day 0 of culture; C7 ‫ס‬ control at day 7 of culture; NE ‫ס‬ not evaluated. See text for additional details. phenomenon was not modified by the addition of t-RA, but it was greatly enhanced by treatment with As 2 O 3 ( Table 3) . Interestingly, cells cultured in the presence of both t-RA and As 2 O 3 exhibited a percentage of apoptotic cells lower than that observed for cells cultured in As 2 O 3 alone. We have reported (14) that retinoic acid induces a loss of the PML/RAR␣ protein in retinoic acid-sensitive APL cells. Since PML/RAR␣ inhibits apoptosis in several systems (9, 23, 24) , we tested whether As 2 O 3 would regulate the expression of this protein (Fig. 2, A) . NB4 and two resistant cell lines, R4 and MR6, were incubated with 1 M t-RA or 1 M As 2 O 3 for 24 hours. Treatment with t-RA induced a down-regulation of PML/RAR␣ in NB4 cells but not in R4 or MR6 cells ( Fig. 2, A; lanes 2, 5,  and 8 ). However, expression of PML/RAR␣ was completely lost after treatment with As 2 O 3 in NB4 cells and in cells of the two resistant cell lines (Fig. 2, A; lanes 3, 6, and 9) , whereas RAR␣ protein expression remained unchanged. The unaltered expression of RAR␣ confirms, as in the case of retinoic acid-treated NB4 cells, the selective regulation of the fusion protein. PML/ RAR␣ expression following As 2 O 3 treatment was also analyzed in the retinoic acid-resistant subclones NB4.006 and NB4.606; similar down-regulation was observed in both cell lines (data not shown).
Cells from a patient with APL were treated in vitro with 1 M t-RA or 1 M As 2 O 3 for 4 days, and the percentage of differentiated cells was determined by use of the NBT reduction assay (Fig. 2, B) . More than 60% of the t-RA-treated cells were NBT positive, whereas As 2 O 3 -treated cells were not differentiated. Nuclear extracts were prepared and subjected to western blot analysis (Fig. 2, C) . Consistent with the in vitro results, the PML/RAR␣ protein level was down-regulated following both retinoic acid treatment and As 2 O 3 treatment. Table 3 . Effect of all-trans-retinoic acid (t-RA) and/or arsenic trioxide (As 2 O 3 ) on apoptosis: percentages of positive cells among leukemia blast cells derived from two patients with acute promyelocytic leukemia* Table 2 , and the percentages of apoptotic cells were determined by use of the Annexin-V labeling method (see text for additional details). C ‫ס‬ control culture (not treated); NE ‫ס‬ not evaluated. (Fig. 3, A-D) . The sizeexclusion HPLC profiles of both NB4 and NB4.606 nuclear extracts show three specific t-RA-binding components with apparent MWs of 50, 110, and 669 kd, representing endogenous RAR␣, PML/RAR␣ monomer, and a high molecular weight complex involving PML/ RAR␣, respectively (Fig. 3, A and B ) (8, 27, 35) . After 16 hours of treatment with 1 M As 2 O 3 , the binding components with MWs of 110 and 669 kd, but not of 50 kd, disappeared from both cell extracts (Fig. 3, C and  D) . Thus, ligand binding to PML/ RAR␣ monomer or multimeric complexes is lost after treatment with As 2 O 3 , consistent with the results of western blot analysis. HPLC profiles of cytosolic extracts from these cells show a peak at 16 kd, representing the cytosolic retinoic acid-binding proteins, that, like the 50-kd peak attributed to unrearranged RAR, is not altered by As 2 O 3 treatment (data not shown).
To determine whether the effects of As 2 O 3 on PML/RAR␣ protein were unique to NB4 cells and their subclones, we studied the promonocytic leukemia cell line U937, which does not express the APL-specific chimeric protein PML/RAR␣. U937/ PR9 is a stable subclone transfected with a PML/RAR␣ complementary DNA under control of a Zn 2+ -inducible promoter (9) . Nuclear extracts from U937/PR9 cells induced with 100 M Zn 2+ for 2 hours and incubated in control medium for 16 hours showed a 669-kd specific t-RA-binding complex similar to the one seen in extracts from NB4 cells (᭹; Fig. 3, E) . However, when extracts of cells treated with 100 M Zn 2+ for 2 hours followed by 1 M As 2 O 3 for 16 hours were examined, nuclear multimeric complex binding to ligand was nearly abolished (᭡; Fig. 3, E ). These data demonstrate that the down-regulation of PML/RAR␣ protein induced by As 2 O 3 is specific for the fusion protein, whether it occurs in APL cells or in other hematopoietic cells artificially expressing PML/RAR␣ protein. 
Reorganization of PML Protein: As 2 O 3 Versus Retinoic Acid
Since As 2 O 3 causes a loss of expression of PML/RAR␣ in retinoic acid-sensitive and retinoic acid-resistant APL cell lines, we examined whether it affects the subcellular localization of PML and PML/RAR␣ in these cells. Immunohistochemical studies on cells before and after 6 or 18 hours of treatment with 1 M As 2 O 3 were performed using a specific anti-PML antibody (Fig. 4, red stain) ; nuclei were localized with DAPI stain (Fig. 4 , blue stain). Before As 2 O 3 treatment, PML and PML/RAR␣ colocalized in the nucleus in a typical, APL-specific, microparticulate pattern both in NB4 cells and in cells of the retinoic acid-resistant cell lines R4 and NB4.306 (Fig. 4, A-C) . Six hours after As 2 O 3 treatment, major decreases were observed in the amounts of nuclear PML and PML/RAR␣ in both NB4 cells and cells of the two resistant cell lines, including NB4.306, a cell line that does not express a detectable level of PML/RAR␣ protein, as determined by western blotting (Fig. 4, D-F) . This reorganization of the PML and PML/RAR␣ staining pattern became more dramatic with longer exposure to As 2 O 3 (Fig. 4 , G-I). The decreased staining observed in this immunohistochemical study is consistent with the loss of PML/RAR␣ protein, which was demonstrated previously in the western blot analysis (Fig. 2, A) , where the fusion protein was not detectable after 24 hours of As 2 O 3 treatment. However, the reorganization of PML and PML/RAR␣ induced by As 2 O 3 is different from the reorganization induced by retinoic acid. Although retinoic acid fails to reconstitute the normal nuclear body pattern of PML in differentiation-resistant clones (12), As 2 O 3 has equal effects on NB4 and the retinoic acid-resistant NB4 subclones. Furthermore, continued treatment with As 2 O 3 leads to a substantially decreased staining of nuclear bodies by the anti-PML antibody, something not seen with retinoic acid treatment. This finding suggests that expression of unrearranged PML is also lost after treatment with As 2 O 3 but not with retinoic acid.
As 2 O 3 and Regulation of Levels of mRNAs Encoding PML, PML/RAR␣, and Retinoid Receptors
We have shown that As 2 O 3 down-regulates PML and PML/ RAR␣ at the protein level (Fig. 2, A; Fig. 4 ). To determine whether this regulation is also observed at the mRNA level, we performed a northern blot analysis using specific PML and RAR␣ probes. The mRNA levels for PML, PML/RAR␣, and RAR␣ remained unchanged following As 2 O 3 treatment for 3 days (data not shown). By use of a ribonuclease protection assay, we also examined the effects of As 2 O 3 on the expression of mRNAs encoding the six retinoid receptor isoforms. In NB4 cells and in the five retinoic acid-resistant subclones tested, RAR␣, RXR␣, and RXR␤ mRNAs are constitutively expressed, whereas expression of RAR␤, RAR␥, and RXR␥ mRNAs is not seen. Although retinoic acid induces RAR␤ expression and down-regulates RXR␣ expression in retinoid-sensitive NB4 cells (36), As 2 O 3 has no detectable effect on RAR␤ and RXR␣ mRNA levels after 3 days. The expression level of CD38 mRNA, up-regulated (increased) during retinoic acid-induced differentiation in HL-60 cells and in retinoic acid-treated NB4 cells (36) (37) (38) , also remained unchanged after As 2 O 3 treatment (data not shown).
As 2 O 3 Interference With
Retinoic Acid-Inducible Type II Transglutaminase (Type II TGase) Activity in NB4 Cells Studies using fresh leukemia cells from patients with APL suggest that As 2 O 3 interferes with retinoic acid-induced differentiation (Table 2) . We investigated, therefore, whether As 2 O 3 exerts an effect on proteins associated with differentiation induced by retinoic acid. Type II TGase activity has been shown to be increased during retinoidinduced differentiation in NB4 cells, mediated through a PML/ RAR␣ signaling pathway (39) . activity was not affected by As 2 O 3 treatment alone, but it was increased by t-RA treatment in a dose-dependent manner. The activity of this enzyme was elevated by about 3000-fold with 100 nM t-RA and by about 4500-fold with 1 M t-RA. However, the induction of type II TGase activity was significantly reduced by pretreatment with As 2 O 3 , whether analyzed on the basis of viable cells or units of protein (data not shown). The status of cell differentiation was also evaluated either morphologically or with the NBT reduction assay (Fig. 5, A) . Cell differentiation was induced by t-RA in a dose-dependent manner; co-treatment with both t-RA and As 2 O 3 reduced the percentage of differentiated cells, in agreement with the decrease in type II TGase activity.
Discussion
Arsenic compounds have been shown to act as co-mutagens or co-carcinogens (40) (41) (42) . However, As 2 O 3 has been recently reported (21, 22) to be effective in treating patients with APL, including those who have relapsed after t-RA treatment, by inducing apoptosis of the leukemia cells. To investigate further the mechanisms of As 2 O 3 action, we tested its effect in vitro on both retinoic acid-sensitive and retinoic acid-resistant NB4 subclones. We found that As 2 O 3 , from concentrations of 0.5-2 M, is able to induce apoptosis without differentiation in NB4 cells and in its retinoic acid-resistant subclones at comparable levels. These in vitro concentrations are within the range found in the plasma of patients with APL who were treated with doses of As 2 O 3 that were well tolerated and that led to complete clinical remission (21, 22) . We previously reported (14) that selective degradation of the PML/RAR␣ protein occurs as NB4 APL cells respond to retinoic acid. Immunohistochemical and western blot analyses have suggested that a loss of PML/RAR␣ protein also occurs with As 2 O 3 treatment in NB4 cells (21, 43) . We find that As 2 O 3 induces the loss of this fusion protein both in NB4 cells and in multiple retinoic acidresistant subclones, as shown by western blot analysis (Fig. 2,  A) , PML and PML/RAR␣ immunohistochemistry (Fig. 4) , and a ligand binding assay (Fig. 3) . This loss of PML/RAR␣ protein is also observed in fresh leukemia cells from patients with APL (Fig. 2, C) . Furthermore, the ability of As 2 O 3 to down-regulate PML/RAR␣ protein selectively is not limited to APL cells. In the U937/PR9 subclone stably expressing PML/RAR␣ protein, As 2 O 3 treatment leads to a loss of the exogenous fusion protein without changing the level of the endogenous RAR␣ protein (Fig. 3, E) .
These data suggest that the loss of PML/RAR␣ protein expression may be important for As 2 O 3 -induced apoptosis. Expression of PML/RAR␣ prevents the apoptosis induced by growth factor withdrawal in U937 and TF-1 cells (9, 23, 24) and leads to the transformation of chicken bone marrow cells in vitro and the induction of acute leukemia in chicken embryos (44) . Furthermore, PML has been shown to function as a growth suppressor, and co-transfection of PML/RAR␣ inhibits the transformation-suppressor function of PML (45, 46) . We have confirmed the report by Chen et al. (21) that both the U937 and HL-60 cells, which do not express PML/RAR␣, are less responsive to doses of As 2 O 3 capable of inducing apoptosis in retinoic acid-sensitive and retinoic acid-resistant APL cells (data not shown). To determine whether PML/RAR␣ expression directly affects the responsiveness of leukemia cells to As 2 O 3 , we compared the response of the U937/PR9 subclone to As 2 O 3 with that of a mock-transfected control. The U937/PR subclone did not show an increased growth inhibition or apoptotic response to As 2 O 3 (data not shown), despite the loss of PML/RAR␣ protein expression. This result suggests that the loss of PML/RAR␣ leads to apoptosis only in cells that are dependent on its expression for their leukemic growth.
NB4.306, one of the retinoic acid-resistant subclones exam- Although retinoids induce terminal cytodifferentiation and As 2 O 3 induces apoptosis of APL cells, both induce the degradation of PML/RAR␣. Thus, PML/RAR␣ may be a common target of both retinoic acid and As 2 O 3 , but with two potential pathways of cellular response. As 2 O 3 induces the loss of PML/ RAR␣ in retinoic acid-resistant cells, suggesting a different mechanism of action on PML/RAR␣ protein. Indeed, our studies on fresh APL cells in vitro show that the addition of As 2 O 3 interferes with the capacity of t-RA to induce cellular differentiation, while the addition of t-RA reduces cell apoptosis induced by As 2 O 3 . This finding suggests that the downstream pathways of response to these agents may compete with each other. To begin to understand how these two agents induce overlapping but distinct pathways, we investigated whether other genes involved in the retinoic acid-signaling pathway also play a role in response to As 2 O 3 treatment. We found that As 2 O 3 has no effect on the expression of genes associated with granulocytic differentiation or on the expression of the six retinoid receptor isoforms. RAR␤ expression, however, is induced by retinoic acid treatment. Since RAR␤ has been linked to retinoid-induced differentiation in a variety of cellular systems and in vivo (47) (48) (49) (50) , its selective induction may play a role in defining the retinoidinduced phenotype in APL cells. Furthermore, the induction of type II TGase by t-RA was impaired by pretreatment with As 2 O 3 , suggesting that As 2 O 3 may suppress gene regulation involved in differentiation. On the other hand, the fusion protein PML/RAR␣ disrupts the normal functions of both unrearranged PML and RAR␣, and our immunohistochemistry data are consistent with a very recent report (51) that the unrearranged PML may be selectively lost after As 2 O 3 treatment. Thus, As 2 O 3 may also differ from retinoic acid in its effects on still poorly defined PML pathways.
APL is a disease with abnormal cell differentiation and proliferation, caused by the fusion of the PML and RAR␣ genes. As 2 O 3 induces apoptosis without differentiation in retinoic acidsensitive and retinoic acid-resistant APL cells. As 2 O 3 , like retinoic acid, induces a loss of PML/RAR␣ protein and may be most effective in cells whose malignant growth is mediated by PML/RAR␣ expression. However, both As 2 O 3 and retinoic acid have additional distinct molecular actions and may interfere with each other's phenotypic response. This circumstance suggests that these two agents, although both effective in treating APL, may not show enhanced activity if given in combination. Further studies of the mechanisms of action of these two agents may better define their respective roles in the treatment of APL and, possibly, of other cancers.
